GGrantIndex
← Search

INVARIANCE MAPPING OF THE COMPLETE HBV GENOME AND TESTING OF MRE11 REPAIR NUCLEASE TOWARD THE IMPROVEMENT OF CRISPR/CAS THERAPY FOR HEPATITIS B

$1,878,970FY2022Department of the ArmyDOD

Invvax, Inc., Cypress

Investigators

View source on USAspending →